Vrije Universiteit Brussel

Quick facts

Marketed products

• Intravenous bumetanide TID
• Lidocaine infiltration · Anesthesia
  Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia.
• Oral chlorthalidone OD
• Oral potassium supplements
• Xylocaine with Epinephrine · Anesthesia
  Xylocaine (lidocaine) blocks sodium channels to produce local anesthesia, while epinephrine causes vasoconstriction to prolong anesthetic duration and reduce systemic absorption.

Phase 3 pipeline

• Methylphenidate Oral Product · Neurology; Psychiatry
  Methylphenidate blocks the reuptake of dopamine and norepinephrine in the central nervous system, increasing their availability at the synapse.
• Reboxetine Pill · Psychiatry / Neurology
  Reboxetine selectively inhibits the reuptake of norepinephrine at the presynaptic neuron, increasing norepinephrine availability in the central nervous system.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vrije Universiteit Brussel portfolio CI brief
• Vrije Universiteit Brussel pipeline updates RSS